Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Bone Biologics Corp (BBLG) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Bone Biologics Corp (BBLG) on October 30, 2026 is 0.3782 $, −2.40 % on the day. Over the past year the price changed by −84.63 %. Market capitalization is 443,706 $, rank 22 among 22 stocks of the same industry with a known capitalization.
Bone Biologics Corp trades on Nasdaq under the ticker BBLG. The company belongs to the Health care sector. The trading history on this page starts on 13 October 2021.
Over the past 52 weeks BBLG has traded between 0.3790 $ and 2.70 $. As of 30 October 2026 the price stood 0.69 % of the way from the 52-week low to the high.
Over one year BBLG shares fell 84.63 %; over six months they fell 71.58 %. Volatility over 90 days is 78.84 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 0.1, below the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
BBLG has a return on equity of −73.66 %, below the sector median of −40.58 %. Return on assets is −65.16 %, below the sector median of −30.08 %.